Eva Jerning

1.2k total citations
16 papers, 919 citations indexed

About

Eva Jerning is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Eva Jerning has authored 16 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Eva Jerning's work include Receptor Mechanisms and Signaling (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Eva Jerning is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Eva Jerning collaborates with scholars based in Sweden, United Kingdom and Spain. Eva Jerning's co-authors include Stefan von Berg, Yafeng Xue, Sven Hellberg, Ratan V. Bhat, Yvonne Nilsson, Mats Ormö, Håkan Hall, Nina Mohell, Félix Hernández and Jesús Ávila and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Eva Jerning

16 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Jerning Sweden 10 552 336 153 139 102 16 919
Ann‐Cathrin Radesäter Sweden 11 429 0.8× 264 0.8× 164 1.1× 102 0.7× 43 0.4× 15 727
Victor I. Ilyin United States 22 699 1.3× 481 1.4× 173 1.1× 133 1.0× 141 1.4× 35 1.1k
María F. Cano‐Abad Spain 17 731 1.3× 337 1.0× 154 1.0× 188 1.4× 83 0.8× 40 1.2k
Brian L. Largent United States 15 638 1.2× 541 1.6× 112 0.7× 162 1.2× 100 1.0× 18 1.3k
Joanne R. Mathiasen United States 19 643 1.2× 443 1.3× 231 1.5× 106 0.8× 155 1.5× 51 1.2k
Atsushi Aoyagi Japan 14 463 0.8× 228 0.7× 386 2.5× 115 0.8× 95 0.9× 19 1.0k
Sandrine Desrayaud Switzerland 19 485 0.9× 339 1.0× 136 0.9× 190 1.4× 157 1.5× 38 1.1k
Alison Easter United Kingdom 10 438 0.8× 311 0.9× 191 1.2× 89 0.6× 29 0.3× 14 803
Tiffany Runyan Garrison United States 16 1.1k 2.0× 579 1.7× 188 1.2× 418 3.0× 71 0.7× 19 1.6k
Donna M. Barten United States 16 341 0.6× 212 0.6× 462 3.0× 237 1.7× 75 0.7× 27 966

Countries citing papers authored by Eva Jerning

Since Specialization
Citations

This map shows the geographic impact of Eva Jerning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Jerning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Jerning more than expected).

Fields of papers citing papers by Eva Jerning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Jerning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Jerning. The network helps show where Eva Jerning may publish in the future.

Co-authorship network of co-authors of Eva Jerning

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Jerning. A scholar is included among the top collaborators of Eva Jerning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Jerning. Eva Jerning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Varnäs, Katarina, Anders Juréus, Peter Johnström, et al.. (2016). Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676. Journal of Pharmacology and Experimental Therapeutics. 358(3). 464–471. 4 indexed citations
2.
Berg, Stefan von, Margareta Bergh, Sven Hellberg, et al.. (2012). Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines. Journal of Medicinal Chemistry. 55(21). 9107–9119. 121 indexed citations
3.
Bhat, Ratan V., Yafeng Xue, Stefan von Berg, et al.. (2003). Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418. Journal of Biological Chemistry. 278(46). 45937–45945. 460 indexed citations
4.
Jerning, Eva, Susanne Rosqvist, & Nina Mohell. (2002). NAD-299 ANTAGONISES 5-HT-STIMULATED AND SPIPERONE-INHIBITED [35S]GTPγS BINDING IN CLONED 5-HT1ARECEPTORS. Journal of Receptors and Signal Transduction. 22(1-4). 483–495. 7 indexed citations
5.
Rényi, Lucy, J. L. Evenden, Christopher J. Fowler, et al.. (2001). The Pharmacological Profile of (R)-3,4-Dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a Selective 5-Hydroxytryptamine1A Receptor Agonist. Journal of Pharmacology and Experimental Therapeutics. 299(3). 883–893. 9 indexed citations
6.
Nordvall, Gunnar, Lars Johansson, Bo‐Ragnar Tolf, et al.. (2000). Synthesis of Novel 5-Substituted 3-Amino-3,4-dihydro-2H-1-benzopyran Derivatives and Their Interactions with the 5-HT1A Receptor. Journal of Medicinal Chemistry. 43(15). 2837–2850. 17 indexed citations
7.
Ross, Svante B., et al.. (1999). Robalzotan (NAD‐299), a Novel Selective 5‐HT1AReceptor Antagonist. CNS Drug Reviews. 5(3). 213–232. 26 indexed citations
8.
Jerning, Eva, et al.. (1998). Receptor binding characteristics of []NAD-299, a new selective 5-HT1A receptor antagonist. European Journal of Pharmacology. 360(2-3). 219–225. 15 indexed citations
9.
10.
11.
Johansson, L. E. B., Daniel Sohn, D M Jackson, et al.. (1997). The Pharmacological Characterization of a Novel Selective 5-Hydroxytryptamine1A Receptor Antagonist, NAD-299. Journal of Pharmacology and Experimental Therapeutics. 283(1). 216–225. 107 indexed citations
12.
Hall, Håkan, Christer Halldin, Eva Jerning, et al.. (1997). Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors. Nuclear Medicine and Biology. 24(5). 389–393. 4 indexed citations
13.
Malmberg, Åsa, Eva Jerning, & Nina Mohell. (1996). Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites. European Journal of Pharmacology. 303(1-2). 123–128. 26 indexed citations
14.
Jerning, Eva, Åsa Malmberg, & Nina Mohell. (1995). In Vitro Receptor Binding Characteristics of the New Dopamine D2Antagonist [125I]NCO-298: Methodological Considerations of High Affinity Binding. Journal of Receptors and Signal Transduction. 15(1-4). 503–515. 5 indexed citations
15.
Hall, Håkan, et al.. (1986). Effects of Remoxipride and some Related New Substituted Salicylamides on Rat Brain Receptors. Acta Pharmacologica et Toxicologica. 58(1). 61–70. 92 indexed citations
16.
Jerning, Eva, et al.. (1981). Comparison of the protective ability of O and K immunity in mice after immunization withEscherichia coli. Current Microbiology. 6(1). 55–59. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann‐Cathrin Radesäter Breakdown of academic impact, for papers by Victor I. Ilyin Breakdown of academic impact, for papers by María F. Cano‐Abad Breakdown of academic impact, for papers by Brian L. Largent Breakdown of academic impact, for papers by Joanne R. Mathiasen Breakdown of academic impact, for papers by Atsushi Aoyagi Breakdown of academic impact, for papers by Sandrine Desrayaud Breakdown of academic impact, for papers by Alison Easter Breakdown of academic impact, for papers by Tiffany Runyan Garrison Breakdown of academic impact, for papers by Donna M. Barten
Rankless by CCL
2026